NYSE:CMD - Cantel Medical Stock Price, Forecast & News

Cantel Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "CMD."

Cantel Medical announced a Semi-Annual dividend on Wednesday, December 18th. Shareholders of record on Friday, January 17th will be paid a dividend of $0.105 per share on Friday, January 31st. The ex-dividend date of this dividend is Thursday, January 16th. This is a boost from Cantel Medical's previous Semi-Annual dividend of $0.10. View Cantel Medical's Dividend History.

Cantel Medical Corp. (NYSE:CMD) announced its earnings results on Tuesday, December, 10th. The company reported $0.65 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.57 by $0.08. The business had revenue of $257.25 million for the quarter, compared to analysts' expectations of $250.70 million. Cantel Medical had a return on equity of 14.91% and a net margin of 4.38%. View Cantel Medical's Earnings History.

3 equities research analysts have issued 1-year price targets for Cantel Medical's stock. Their forecasts range from $82.00 to $108.00. On average, they expect Cantel Medical's stock price to reach $95.00 in the next year. This suggests a possible upside of 36.7% from the stock's current price. View Analyst Price Targets for Cantel Medical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cantel Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cantel Medical.

News headlines about CMD stock have trended positive this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cantel Medical earned a daily sentiment score of 2.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Cantel Medical.

Some companies that are related to Cantel Medical include Novocure (NVCR), ABIOMED (ABMD), Hill-Rom (HRC), Penumbra (PEN), Haemonetics (HAE), Globus Medical (GMED), Tandem Diabetes Care (TNDM), Integra Lifesciences (IART), ICU Medical (ICUI), Nevro (NVRO), NuVasive (NUVA), Glaukos (GKOS), Irhythm Technologies (IRTC), Merit Medical Systems (MMSI) and Inspire Medical Systems (INSP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cantel Medical investors own include THERAPIX BIOSCI/S (TRPX), Gilead Sciences (GILD), NVIDIA (NVDA), ZIOPHARM Oncology (ZIOP), JPMorgan Chase & Co. (JPM), Cisco Systems (CSCO), Exelixis (EXEL), Netflix (NFLX), Paypal (PYPL) and Supernus Pharmaceuticals (SUPN).

Shares of CMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CMD stock can currently be purchased for approximately $69.50.

Cantel Medical has a market capitalization of $2.96 billion and generates $918.16 million in revenue each year. The company earns $55.04 million in net income (profit) each year or $2.37 on an earnings per share basis. Cantel Medical employs 2,775 workers across the globe.View Additional Information About Cantel Medical.

The official website for Cantel Medical is http://www.cantelmedical.com/.

Cantel Medical's mailing address is 150 CLOVE ROAD, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-890-7220 or via email at [email protected]